Helen Ling

5.7k total citations
56 papers, 3.2k citations indexed

About

Helen Ling is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Helen Ling has authored 56 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Neurology, 15 papers in Physiology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Helen Ling's work include Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (25 papers) and Alzheimer's disease research and treatments (15 papers). Helen Ling is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (25 papers) and Alzheimer's disease research and treatments (15 papers). Helen Ling collaborates with scholars based in United Kingdom, United States and Australia. Helen Ling's co-authors include Janice L. Holton, Andrew J. Lees, Tamás Révész, John Hardy, Yasmine T. Asi, Sean S. O’Sullivan, Luke A. Massey, Henry Houlden, Dominic Paviour and Niall Quinn and has published in prestigious journals such as Brain, Neurology and Diabetes Care.

In The Last Decade

Helen Ling

55 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Ling United Kingdom 30 2.5k 973 898 656 483 56 3.2k
Kenya Nishioka Japan 32 1.7k 0.7× 750 0.8× 749 0.8× 529 0.8× 543 1.1× 130 3.3k
Yvette Bordelon United States 26 1.6k 0.6× 834 0.9× 404 0.4× 368 0.6× 499 1.0× 70 2.5k
Felix Geser United States 25 2.8k 1.1× 581 0.6× 951 1.1× 748 1.1× 895 1.9× 40 3.4k
Francesco Roselli Germany 25 851 0.3× 664 0.7× 585 0.7× 314 0.5× 649 1.3× 78 2.2k
Vincenzo La Bella Italy 34 1.9k 0.8× 559 0.6× 344 0.4× 354 0.5× 934 1.9× 112 3.3k
Nikunj K. Patel United Kingdom 25 1.6k 0.6× 1.7k 1.8× 503 0.6× 427 0.7× 639 1.3× 53 3.8k
Shigeki Kuzuhara Japan 35 2.1k 0.9× 823 0.8× 910 1.0× 725 1.1× 867 1.8× 190 3.8k
Sadako Kuno Japan 33 1.8k 0.7× 1.5k 1.5× 354 0.4× 486 0.7× 622 1.3× 91 3.5k
Kimihito Arai Japan 25 1.2k 0.5× 686 0.7× 592 0.7× 460 0.7× 573 1.2× 58 2.5k
Andrzej Friedman Poland 24 1.6k 0.6× 537 0.6× 586 0.7× 387 0.6× 378 0.8× 85 2.5k

Countries citing papers authored by Helen Ling

Since Specialization
Citations

This map shows the geographic impact of Helen Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Ling more than expected).

Fields of papers citing papers by Helen Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Ling. The network helps show where Helen Ling may publish in the future.

Co-authorship network of co-authors of Helen Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Ling. A scholar is included among the top collaborators of Helen Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Ling. Helen Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mosquera-Lopez, Clara, Peter G. Jacobs, Katrina Ramsey, et al.. (2025). Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study. Diabetes Care. 48(10). 1766–1773. 1 indexed citations
2.
Ling, Helen, Marla Gearing, Beth A. Dombroski, et al.. (2020). Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R. Neurobiology of Disease. 146. 105079–105079. 4 indexed citations
3.
Klingstedt, Therése, Bernardino Ghetti, Janice L. Holton, et al.. (2019). Luminescent conjugated oligothiophenes distinguish between α-synuclein assemblies of Parkinson’s disease and multiple system atrophy. Acta Neuropathologica Communications. 7(1). 193–193. 34 indexed citations
4.
Batla, Amit, Eduardo De Pablo‐Fernández, Roberto Erro, et al.. (2018). Young‐onset multiple system atrophy: Clinical and pathological features. Movement Disorders. 33(7). 1099–1107. 24 indexed citations
5.
Gelpí, Ellen, Romana Höftberger, Francesc Graus, et al.. (2016). Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathologica. 132(4). 531–543. 152 indexed citations
6.
Ling, Helen. (2016). Clinical Approach to Progressive Supranuclear Palsy. Journal of Movement Disorders. 9(1). 3–13. 50 indexed citations
7.
Ling, Helen, Laura Silveira‐Moriyama, Tamás Révész, et al.. (2015). Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?. Journal of Neurology Neurosurgery & Psychiatry. 87(6). 633–641. 10 indexed citations
8.
Ling, Helen, John Hardy, & Henrik Zetterberg. (2015). Neurological consequences of traumatic brain injuries in sports. Molecular and Cellular Neuroscience. 66(Pt B). 114–122. 127 indexed citations
9.
Kiely, Aoife P., Helen Ling, Yasmine T. Asi, et al.. (2015). Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Molecular Neurodegeneration. 10(1). 41–41. 90 indexed citations
10.
Ling, Helen, Eleanna Kara, Tamás Révész, et al.. (2014). Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer. Acta Neuropathologica Communications. 2(1). 24–24. 22 indexed citations
11.
Massey, Luke A., Hans Rolf Jäger, Dominic Paviour, et al.. (2013). The midbrain to pons ratio. Neurology. 80(20). 1856–1861. 120 indexed citations
12.
Kiely, Aoife P., Yasmine T. Asi, Eleanna Kara, et al.. (2013). α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?. Acta Neuropathologica. 125(5). 753–769. 349 indexed citations
13.
Ling, Helen, Eleanna Kara, Rina Bandopadhyay, et al.. (2013). TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT. Neurobiology of Aging. 34(12). 2889.e5–2889.e9. 45 indexed citations
14.
Petrović, Igor, Antonio Martín‐Bastida, Luke A. Massey, et al.. (2012). MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy. Journal of Neurology. 260(4). 1031–1036. 16 indexed citations
15.
Ling, Helen, et al.. (2011). Creutzfeldt Jacob disease presenting as progressive supranuclear palsy. UCL Discovery (University College London).
16.
Ling, Helen, James M. Polke, Mary G. Sweeney, et al.. (2011). An intragenic duplication in guanosine triphosphate cyclohydrolase‐1 gene in a dopa‐responsive dystonia family. Movement Disorders. 26(5). 905–909. 9 indexed citations
17.
Ling, Helen, Mark Braschinsky, Pille Taba, et al.. (2011). Decades of delayed diagnosis in 4 levodopa‐responsive young‐onset monogenetic parkinsonism patients. Movement Disorders. 26(7). 1337–1340. 3 indexed citations
18.
Ling, Helen, Sean S. O’Sullivan, JL Holton, et al.. (2010). Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain. 133(7). 2045–2057. 278 indexed citations
19.
Ling, Helen & Andrew J. Lees. (2009). How Can Neuroimaging Help in the Diagnosis of Movement Disorders?. Neuroimaging Clinics of North America. 20(1). 111–123. 6 indexed citations
20.
Bhidayasiri, Roongroj & Helen Ling. (2008). Multiple System Atrophy. The Neurologist. 14(4). 224–237. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenya Nishioka Breakdown of academic impact, for papers by Yvette Bordelon Breakdown of academic impact, for papers by Felix Geser Breakdown of academic impact, for papers by Francesco Roselli Breakdown of academic impact, for papers by Vincenzo La Bella Breakdown of academic impact, for papers by Nikunj K. Patel Breakdown of academic impact, for papers by Shigeki Kuzuhara Breakdown of academic impact, for papers by Sadako Kuno Breakdown of academic impact, for papers by Kimihito Arai Breakdown of academic impact, for papers by Andrzej Friedman
Rankless by CCL
2026